The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, January 10, 2019
Teva announced the FDA has approved ProAir Digihaler inhalation powder, a digital inhaler with built-in sensors which connects to a mobile app and ...
read more
Tuesday, January 08, 2019
Sun Pharmaceutical is voluntarily recalling three lots of Vecuronium Bromide for Injection, 10 mg and one lot of Vecuronium Bromide for Injection, 20 ...
read more
Wednesday, January 02, 2019
Heron Therapeutics announced the FDA has accepted the NDA for Heron's investigational agent, HTX-011, and has granted it a Priority Review designation...
read more
Friday, December 28, 2018
The FDA has approved VAXELIS for use in children from 6 weeks through 4 years of age. VAXELIS was developed as part of a joint partnership between ...
read more
Friday, December 28, 2018
Kala Pharmaceuticals announced the NDA for KPI-121 0.25% has been accepted for review by the FDA.
read more
Wednesday, December 26, 2018
Braeburn announced the FDA has granted tentative approval of BRIXADI (buprenorphine) extended-release weekly injections.
read more
Wednesday, December 19, 2018
Alcon has acquired Tear Film Innovations, a privately-held company and manufacturer of the iLux Device, a therapeutic device used to treat Meibomian ...
read more
Tuesday, December 18, 2018
Croda has signed a definitive agreement with Brenntag Nordic A/S to acquire Brenntag Biosector, for a total consideration of €72 million in cash.
read more
Thursday, December 13, 2018
Adynxx announced receipt of Notice of Award from the NIDA for an award to support the clinical development of brivoligide injection for postoperative ...
read more
Tuesday, December 11, 2018
Avanir Pharmaceuticals announced that it will terminate the license agreement with Optinose for intranasal migraine medication ONZETRA Xsail (...
read more
Thursday, November 29, 2018
A recent study in preschoolers with cystic fibrosis conducted by Cystic Fibrosis Foundation Therapeutics used PARI's LC Sprint Jr. nebulizer, Vios PRO...
read more
Monday, November 26, 2018
CURE has secured a new registration with the Drug Enforcement Administration (DEA) as a manufacturer authorized to handle Schedule 1 controlled ...
read more
Tuesday, November 20, 2018
Aquestive Therapeutics has received a complete response letter from the FDA in regards to its New Drug Application for tadalafil oral film.
read more
Tuesday, November 20, 2018
Medunik USA announced Siklos (hydroxyurea), an FDA-approved orphan drug, is now available in 1,000 mg triple-scored tablets to help optimize dosing.
read more
Friday, November 09, 2018
GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline and Innoviva announced the European Commission has authorized an expanded label for once-daily Trelegy Ellipta (fluticasone furoate/...
read more